-
1 Comment
Skotan S.A. is currently in a long term downtrend where the price is trading 4.8% below its 200 day moving average.
Skotan S.A.'s total revenue rose by 112.1% to $2M since the same quarter in the previous year.
Its net income has increased by 65.1% to $-492K since the same quarter in the previous year.
Finally, its free cash flow grew by 83.0% to $-247K since the same quarter in the previous year.
Based on the above factors, Skotan S.A. gets an overall score of 3/5.
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| ISIN | PLSKTAN00010 |
| Sector | Basic Materials |
| Industry | Chemicals |
| Beta | 0.85 |
|---|---|
| Market Cap | 88M |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | 0.0% |
Skotan SA engages in the research and development in the areas of dietetics, animal nutrition, bioremediation, and agrotechnological processes in Poland. The company provides human dietary supplement products under the Estrovita brand. It also offers Yarrowia Equinox; Yarrowia Canifelox; and Yarrowia Farminox; and dietary supplements, food additives, functional foods, and cosmetic raw materials. The company sells its products through chain pharmacies, pharmaceutical wholesalers, bio/eko stores, drugstores, e-commerce, zoological networks, veterinary offices, zoological and veterinary wholesalers, animal feed and supplementary mixture producers, and contract manufacturers. Skotan SA was founded in 1995 and is based in Chorzów, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SKT.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
